Bivalirudin burst dosing in children supported with paracorporeal ventricular assist devices: A single-center experience
Children supported with paracorporeal ventricular assist devices (VADs) are at increased risk of thrombotic complications despite anticoagulation advances. Bivalirudin, a direct thrombin inhibitor, has emerged as an alternative to heparin through initiatives led by ACTION. At our institution, a burs...
Uloženo v:
| Hlavní autoři: | , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2026-08-01
|
| Edice: | JHLT Open |
| Témata: | |
| On-line přístup: | http://www.sciencedirect.com/science/article/pii/S2950133426001126 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
